0001062993-23-015062.txt : 20230718
0001062993-23-015062.hdr.sgml : 20230718
20230718204104
ACCESSION NUMBER: 0001062993-23-015062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230714
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gregory Kathryn
CENTRAL INDEX KEY: 0001768530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40228
FILM NUMBER: 231095415
MAIL ADDRESS:
STREET 1: 305 THAYER POND ROAD
CITY: WILTON
STATE: CT
ZIP: 06897
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III
CENTRAL INDEX KEY: 0001842939
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-494-3296
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-07-14
0001842939
ALPHA HEALTHCARE ACQUISITION CORP III
CTCX
0001768530
Gregory Kathryn
C/O CARMELL THERAPEUTICS CORPORATION
2403 SIDNEY STREET, SUITE 300
PITTSBURGH
PA
15203
1
0
0
0
0
Stock Option (right to buy)
2.27
2023-07-14
4
A
0
9161
A
2030-07-17
Common Stock
9161
9161
D
Stock Option (right to buy)
2.27
2023-07-14
4
A
0
6154
A
2031-02-10
Common Stock
6154
6154
D
Stock Option (right to buy)
2.11
2023-07-14
4
A
0
61563
A
2031-09-23
Common Stock
61563
61563
D
Options to purchase 9,161 shares of common stock of Legacy Carmell (as defined below) granted on July 17, 2020, which vest as follows: 25% vested on July 17, 2021, July 17, 2022 and July 17, 2023 and the remaining 25% becomes vested in 12 equal monthly installments thereafter, subject to continued service through each vesting date.
Options to purchase 6,154 shares of common stock of Legacy Carmell granted on February 10, 2021, which vest as follows: 25% vested on February 10, 2022 and February 10, 2023 and the remaining 50% becomes vested in 24 equal monthly installments thereafter, subject to continued service through each vesting date.
Options to purchase 61,563 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2023 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation.
/s/ Randolph W. Hubbell, Attorney-in-Fact
2023-07-18